Effects of Aerobic Exercise During the Early Rehabilitation After Ischemic Stroke
EXERTION
Aerobic Exercise in the the Early Stroke Rehabilitation - Effects on Motor Function, Cognition, Physical Comfort and the Immune System
1 other identifier
interventional
39
1 country
1
Brief Summary
The goal of this clinical trial is to study the effects of aerobic exercise during the early rehabilitation after ischemic stroke. The main questions it aims to answer are:
- How is the recovery of motor function affected by regularly walking during the first 90 days after an ischemic stroke?
- Does regularly walking during the first 90 days after ischemic stroke affect cognition, physical comfort and the immune system? Participants will exert a heart rate controlled walking programme of walking 3-5 times 30-45 minutes per week. Researchers will compare the recovery of the walking group to a control group without any demands regarding physical exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2022
CompletedFirst Submitted
Initial submission to the registry
December 20, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedJune 3, 2024
May 1, 2024
1.1 years
December 20, 2022
May 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor function
Recovery of motor function is assessed by fugl-meyer assessment (FMA). The FMA-UE (upper extremity) is measured in a score with a maximum of 66 points for motor function, the FMA-LE (lower extremity) extends up to a sum score of 34 points for motor function.
90 days
Secondary Outcomes (5)
Cognition
90 days
Fatigue
90 days
Physical Comfort
90 days
Flow cytometry analysis of cryoasservated peripheral blood mononuclear cells (PBMC)
90 days
Structural axonal changes
90 days
Study Arms (2)
Exercise Group
EXPERIMENTALParticipants will exert a heart rate controlled aerobic walking training 3-5 times per week for 30-45 minutes per training. This exercise as well as the daily amount of steps will be assessed via smartwatch.
No Exercise Group
NO INTERVENTIONParticipants receive no demands regarding the daily exercise. Their daily amount of steps will be assessed via smartwach.
Interventions
Eligibility Criteria
You may qualify if:
- initial NIHSS or NIHSS determined at the moment of maximum deterioration 1-18
- age \> 18
- ischemic stroke
- pre-stroke independence
- sufficient motivation / patient's desire to cooperate / exercise for 3-5x/week for 30-45 min
You may not qualify if:
- transient ischemic attack
- premorbid motor disability / musculoskeletal injury / severe arthritis impairing degree of movement
- balance and transfer function that requires assistance
- cardiac disease not allowing to perform aerobic training
- inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Münster
Münster, Northrine-Westphalia, D-48149, Germany
Related Publications (1)
Straeten FA, van Zyl S, Maus B, Bauer J, Raum H, Gross CC, Bruchmann S, Landmeyer NC, Faber C, Minnerup J, Schmidt-Pogoda A. EXERTION: a pilot trial on the effect of aerobic, smartwatch-controlled exercise on stroke recovery: effects on motor function, structural repair, cognition, mental well-being, and the immune system. Neurol Res Pract. 2023 May 11;5(1):18. doi: 10.1186/s42466-023-00244-w.
PMID: 37170385DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antje Schmidt-Pogoda, MD
University Hospital Muenster
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2022
First Posted
January 19, 2023
Study Start
October 26, 2022
Primary Completion
December 1, 2023
Study Completion
February 1, 2024
Last Updated
June 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share